Literature DB >> 7559150

Expression and androgenic regulation of human prostate-specific kallikreins.

C Y Young1, P E Andrews, D J Tindall.   

Abstract

In vitro studies suggest that the protease activity of PSA might play a functional role to facilitate the growth and spreading of cancerous prostatic cells. hK2 may have similar properties. Further investigation to prove their in vivo effects is required. Regulation of PSA and hKLK2 gene expression is mediated not only by androgens, but also by a number of autocrine and paracrine factors, suggesting that the control mechanisms for expression of these genes are complex and multifaceted. Such factors may also be integral for the growth and differentiation of prostate cells. Thus PSA and hKLK2 may serve as useful markers to study the regulation of gene expression during cell growth and differentiation of the prostate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559150

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  12 in total

1.  Identification of two novel cis-elements in the promoter of the prostate-specific antigen gene that are required to enhance androgen receptor-mediated transactivation.

Authors:  J Zhang; S Zhang; P E Murtha; W Zhu; S S Hou; C Y Young
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

2.  Association Between Serum Testosterone and Serum PSA Among Men With and Without Partial Androgen Deficiency.

Authors:  A Shukla; B Sharda; S Sharma; S Bhardwaj; U Kailash; R Kalani; L Satyanarayana; A Shrivastava
Journal:  Indian J Clin Biochem       Date:  2018-07-31

3.  PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach.

Authors:  Tapan K Bera; Rangan Maitra; Carlo Iavarone; Giuliana Salvatore; Vasantha Kumar; James J Vincent; B K Sathyanarayana; Paul Duray; B K Lee; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

4.  Association between Liver Fibrosis and Serum PSA among U.S. Men: National Health and Nutrition Examination Survey (NHANES), 2001-2010.

Authors:  Anqi Wang; Mariana Lazo; H Ballentine Carter; John D Groopman; William G Nelson; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-03       Impact factor: 4.254

5.  Changes in prostate-specific antigen (PSA) level correlate with growth inhibition of prostate cancer cells treated in vitro with a novel anticancer drug, irofulven.

Authors:  A L Woynarowska BAHigdon; R M Muñoz; P Bushong; S J Waters
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

6.  EPA Modulates KLK Genes via miR-378: A Potential Therapy in Prostate Cancer.

Authors:  Kai-Jie Yu; De-Yi Ji; Ming-Li Hsieh; Cheng-Keng Chuang; See-Tong Pang; Wen-Hui Weng
Journal:  Cancers (Basel)       Date:  2022-06-06       Impact factor: 6.575

7.  Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer.

Authors:  Sarah B Peskoe; Corinne E Joshu; Sabine Rohrmann; Katherine A McGlynn; Sarah J Nyante; Gary Bradwin; Adrian S Dobs; Norma Kanarek; William G Nelson; Elizabeth A Platz
Journal:  Prostate       Date:  2015-04-28       Impact factor: 4.104

8.  Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.

Authors:  Bekir Cinar; Fan Yeung; Hiroyuki Konaka; Marty W Mayo; Michael R Freeman; Haiyen E Zhau; Leland W K Chung
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

9.  Identification of androgen-regulated genes in human prostate.

Authors:  Markku H Vaarala; Pasi Hirvikoski; Saila Kauppila; Timo K Paavonen
Journal:  Mol Med Rep       Date:  2012-06-19       Impact factor: 2.952

10.  Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.

Authors:  David Pépin; Zhong-Qi Shao; Geneviève Huppé; Andrea Wakefield; Chee-Wui Chu; Zahra Sharif; Barbara C Vanderhyden
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.